{"title":"Effect of magnesium sulfate and personalised dietary guidance on hemodynamics and inflammatory cytokines in pregnancy-induced hypertension.","authors":"Miao Shen, Ying Zhuang, Yaning Zheng, Mengqin Wang, Jiexun Wang, Shuoying Lyu","doi":"10.5937/jomb0-57165","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pregnancy-induced hypertension (PIH) is a significant cause of maternal and neonatal complications, often linked to vascular dysfunction and inflammatory responses. This study aimed to evaluate the effects of magnesium sulfate (MS) combined with personalised dietary guidance on hemodynamic parameters and inflammatory cytokine profiles in PIH patients.</p><p><strong>Methods: </strong>A total of 108 PIH patients were randomly assigned to two groups: a research group (MS and dietary guidance) and a control group (dietary guidance only). Hemodynamic parameters, including systolic and diastolic blood pressure (SBP, DBP), plasma viscosity (PV), and erythrocyte aggregation index (EI), were measured, along with inflammatory cytokines [Interleukin-6 (IL-6), Interleukin-10 (IL-10), and Interleukin-1b (IL-1b)], before and after treatment.</p><p><strong>Results: </strong>The research group, which received both MS and dietary guidance, showed significant reductions in SBP, DBP, PV, and EI compared to the control group. Additionally, inflammatory cytokines IL-6 and IL-1b were significantly reduced in the research group, indicating an improvement in the inflammatory response. While IL-10 levels decreased in both groups, this change was not statistically significant.</p><p><strong>Conclusions: </strong>Combining magnesium sulfate and personalised dietary guidance effectively improves hemodynamic stability and reduces inflammatory markers in PIH patients.</p>","PeriodicalId":16175,"journal":{"name":"Journal of Medical Biochemistry","volume":"44 6","pages":"1219-1226"},"PeriodicalIF":1.5000,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12497461/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Biochemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5937/jomb0-57165","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Pregnancy-induced hypertension (PIH) is a significant cause of maternal and neonatal complications, often linked to vascular dysfunction and inflammatory responses. This study aimed to evaluate the effects of magnesium sulfate (MS) combined with personalised dietary guidance on hemodynamic parameters and inflammatory cytokine profiles in PIH patients.
Methods: A total of 108 PIH patients were randomly assigned to two groups: a research group (MS and dietary guidance) and a control group (dietary guidance only). Hemodynamic parameters, including systolic and diastolic blood pressure (SBP, DBP), plasma viscosity (PV), and erythrocyte aggregation index (EI), were measured, along with inflammatory cytokines [Interleukin-6 (IL-6), Interleukin-10 (IL-10), and Interleukin-1b (IL-1b)], before and after treatment.
Results: The research group, which received both MS and dietary guidance, showed significant reductions in SBP, DBP, PV, and EI compared to the control group. Additionally, inflammatory cytokines IL-6 and IL-1b were significantly reduced in the research group, indicating an improvement in the inflammatory response. While IL-10 levels decreased in both groups, this change was not statistically significant.
Conclusions: Combining magnesium sulfate and personalised dietary guidance effectively improves hemodynamic stability and reduces inflammatory markers in PIH patients.
期刊介绍:
The JOURNAL OF MEDICAL BIOCHEMISTRY (J MED BIOCHEM) is the official journal of the Society of Medical Biochemists of Serbia with international peer-review. Papers are independently reviewed by at least two reviewers selected by the Editors as Blind Peer Reviews. The Journal of Medical Biochemistry is published quarterly.
The Journal publishes original scientific and specialized articles on all aspects of
clinical and medical biochemistry,
molecular medicine,
clinical hematology and coagulation,
clinical immunology and autoimmunity,
clinical microbiology,
virology,
clinical genomics and molecular biology,
genetic epidemiology,
drug measurement,
evaluation of diagnostic markers,
new reagents and laboratory equipment,
reference materials and methods,
reference values,
laboratory organization,
automation,
quality control,
clinical metrology,
all related scientific disciplines where chemistry, biochemistry, molecular biology and immunochemistry deal with the study of normal and pathologic processes in human beings.